NEW YORK, April 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cara Therapeutics, Inc. CARA, MGE Energy Inc. MGEE, IDEXX Laboratories, Inc. IDXX, Sterling Construction Company Inc STRL, TTM Technologies, Inc. TTMI, and Regis Corporation RGS, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
CARA DOWNLOAD: http://Fundamental-Markets.com/register/?so=CARA
MGEE DOWNLOAD: http://Fundamental-Markets.com/register/?so=MGEE
IDXX DOWNLOAD: http://Fundamental-Markets.com/register/?so=IDXX
STRL DOWNLOAD: http://Fundamental-Markets.com/register/?so=STRL
TTMI DOWNLOAD: http://Fundamental-Markets.com/register/?so=TTMI
RGS DOWNLOAD: http://Fundamental-Markets.com/register/?so=RGS
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Cara Therapeutics, Inc. CARA, MGE Energy Inc. MGEE, IDEXX Laboratories, Inc. IDXX, Sterling Construction Company Inc STRL, TTM Technologies, Inc. TTMI, and Regis Corporation RGS on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed April 27th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
CARA THERAPEUTICS, INC. (CARA) REPORT OVERVIEW
Cara Therapeutics' Recent Financial Performance
For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cara Therapeutics reported revenue of $0.91MM vs $0.09MM (up 959.30%) and basic earnings per share -$1.86 vs -$2.10. Cara Therapeutics is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.81. The estimated EPS forecast for the next fiscal year is -$2.06 and is expected to report on March 21st, 2019.
To read the full Cara Therapeutics, Inc. (CARA) report, download it here: http://Fundamental-Markets.com/register/?so=CARA
-----------------------------------------
MGE ENERGY INC. (MGEE) REPORT OVERVIEW
MGE Energy's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, MGE Energy reported revenue of $140.27MM vs $138.93MM (up 0.97%) and basic earnings per share $1.04 vs $0.42 (up 147.62%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, MGE Energy reported revenue of $563.10MM vs $544.75MM (up 3.37%) and basic earnings per share $2.82 vs $2.18 (up 29.36%). MGE Energy is expected to report earnings on May 4th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.56. The estimated EPS forecast for the next fiscal year is $2.40 and is expected to report on February 22nd, 2019.
To read the full MGE Energy Inc. (MGEE) report, download it here: http://Fundamental-Markets.com/register/?so=MGEE
-----------------------------------------
IDEXX LABORATORIES, INC. (IDXX) REPORT OVERVIEW
IDEXX Laboratories' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, IDEXX Laboratories reported revenue of $506.12MM vs $443.00MM (up 14.25%) and basic earnings per share $0.44 vs $0.58 (down 24.14%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, IDEXX Laboratories reported revenue of $1,969.06MM vs $1,775.42MM (up 10.91%) and basic earnings per share $3.00 vs $2.47 (up 21.46%). IDEXX Laboratories is expected to report earnings on May 4th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.65. The estimated EPS forecast for the next fiscal year is $4.86 and is expected to report on February 7th, 2019.
To read the full IDEXX Laboratories, Inc. (IDXX) report, download it here: http://Fundamental-Markets.com/register/?so=IDXX
-----------------------------------------
STERLING CONSTRUCTION COMPANY INC (STRL) REPORT OVERVIEW
Sterling Construction's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Sterling Construction reported revenue of $253.91MM vs $168.35MM (up 50.83%) and basic earnings per share $0.12 vs -$0.22. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Sterling Construction reported revenue of $957.96MM vs $690.12MM (up 38.81%) and basic earnings per share $0.44 vs -$0.40. Sterling Construction is expected to report earnings on May 7th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.09. The estimated EPS forecast for the next fiscal year is $1.29 and is expected to report on March 4th, 2019.
To read the full Sterling Construction Company Inc (STRL) report, download it here: http://Fundamental-Markets.com/register/?so=STRL
-----------------------------------------
TTM TECHNOLOGIES, INC. (TTMI) REPORT OVERVIEW
TTM Technologies' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, TTM Technologies reported revenue of $739.35MM vs $706.53MM (up 4.64%) and basic earnings per share $0.48 vs -$0.03. For the twelve months ended December 31st, 2017 vs December 31st, 2016, TTM Technologies reported revenue of $2,658.59MM vs $2,533.36MM (up 4.94%) and basic earnings per share $1.22 vs $0.35 (up 248.57%). TTM Technologies is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.33. The estimated EPS forecast for the next fiscal year is $1.23 and is expected to report on February 6th, 2019.
To read the full TTM Technologies, Inc. (TTMI) report, download it here: http://Fundamental-Markets.com/register/?so=TTMI
-----------------------------------------
REGIS CORPORATION (RGS) REPORT OVERVIEW
Regis' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Regis reported revenue of $308.52MM vs $315.25MM (down 2.14%) and basic earnings per share $0.70 vs -$0.05. For the twelve months ended June 30th, 2017 vs June 30th, 2016, Regis reported revenue of $1,691.89MM vs $1,790.87MM (down 5.53%) and basic earnings per share -$0.35 vs -$0.23. Regis is expected to report earnings on May 1st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.18.
To read the full Regis Corporation (RGS) report, download it here: http://Fundamental-Markets.com/register/?so=RGS
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
